FDA Basics for Industry Goes LiveFDA Basics for Industry Goes Live
January 7, 2011
WASHINGTONFDA launched FDA Basics for Industry, a website that contains basic information about the regulatory process, including information that is frequently requested by industry designed to help companies and others save time and resources in their interactions with the agency.
"Clarity and consistency are pillars of an effective regulatory system that efficiently regulates products essential to health," said FDA Commissioner Margaret Hamburg, M.D. "In order to succeed, FDA must clearly communicate standards and expectations to the industries it regulates."
This site follows FDAs newly created web page FDA Basics that features questions, answers, videos, and other materials describing how FDA works to protect and promote public health. The page has been viewed by more than 900,000 people worldwide, according to the agency.
Part of the agency's ongoing transparency initiative, these sites included in the 19 action items contained in a 46-page report titled "FDA Transparency Initiative: Improving Transparency to Regulated Industry." Other action items include:
setting an agency-wide expectation that e-mail questions to the FDA involving the regulatory process will, whenever possible, receive an answer within five business days, or a response stating when an answer can be expected
making agency presentations at key meetings widely available
developing and executing a project to promote uniform processes and procedures across field districts.
"We have heard from small and large companies about the need for FDA to more clearly communicate about its standards and expectationsboth for regulated products generally and for specific applications," said Principal Deputy Commissioner Joshua Sharfstein, M.D., chairman of the agency's Transparency Task Force.
The report also contains five draft proposals to improve FDA's transparency to regulated industry. The draft proposals, available for public comment for 60 days, include publishing a timeline on the FDA website for high priority guidance documents in development. FDA would disclose dates for publication of the draft guidance, receipt of public comments and publication of the final guidance.
The agency also has established an online performance program for FDA offices nationwide. Called FDA-TRACK, the program features monthly metrics for more than 100 agency offices and provides insight for the public into the FDA's decision-making and regulatory activities.
Commissioner Hamburg launched the FDA's Transparency Initiative in June 2009 in response to President Obama's commitment to openness in government and steps taken by the U.S. Department of Health and Human Services to make transparency a priority.
You May Also Like
Advancing gender equity in the nutraceutical industrySep 25, 2023
CRN petition to FTC: RCTs aren’t required to substantiate ‘health-benefit’ claimsSep 22, 2023
Exercise recovery: Electrolytes, hydration and combating fatigue – SupplySide intensive webinarSep 22, 2023
Collagen peptide ingredient solutions for seniors’ changing needs – infographicSep 19, 2023